Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Dalton Transactions (Cambridge, England : 2003)|September 6, 2018
Two-electron redox-active tricyano iron(ii) complex with 2,4,6-tris(2-pyrimidyl)-1,3,5-triazine as a building block for coordination polymersTakuya Shiga, Haruka Miyamoto, Graham N Newton, et al.
Dalton Transactions (Cambridge, England : 2003)|February 13, 2023
Tetranuclear [Cu3Ln] complexes derived from a tetraketone-type ligandTakuya Shiga, Haruka Miyamoto, Yukiko Okamoto, et al.
Dalton Transactions (Cambridge, England : 2003)|February 6, 2019
Substituent dependence on the spin crossover behaviour of mononuclear Fe(ii) complexes with asymmetric tridentate ligandsRyo Saiki, Haruka Miyamoto, Hajime Sagayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 18, 2024
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver diseaseKeito Suzuki, Nobuharu Tamaki, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 26, 2024
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis BNobuharu Tamaki, Mayu Higuchi, Taisei Keitoku, et al.
BMC Gastroenterology|June 17, 2023
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver diseaseShun Ishido, Nobuharu Tamaki, Yuka Takahashi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 31, 2023
Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis BShun Ishido, Nobuharu Tamaki, Naoki Uchihara, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2023
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver DiseaseMichiko Yamada-Shimizu, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Plos One|October 14, 2025
Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and olderKenta Takaura, Kaoru Tsuchiya, Mina Taguchi, et al.
Clinical Case Reports|July 7, 2023
Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling testShun Ishido, Nobuharu Tamaki, Kento Inada, et al.
Pageof 2